(Q36922266)

17 August 2017

1 reference

title

PEGylated bioactive molecules in biodegradable polymer microparticles (English)

1 reference

17 August 2017

0 references

Paul G Schmidt

1

1 reference

17 August 2017

Kathleen M Campbell

series ordinal

2

1 reference

17 August 2017

Kenneth D Hinds

series ordinal

3

1 reference

17 August 2017

Gary P Cook

series ordinal

4

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

Expert Opinion on Biological Therapy

17 August 2017

1 reference

17 August 2017

7

1 reference

17 August 2017

9

1 reference

17 August 2017

1427-1436

1 reference

Poly(DL-lactide-co-glycolide)/norethisterone microcapsules: an injectable biodegradable contraceptive

17 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

pH and osmotic pressure inside biodegradable microspheres during erosion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Determination of water-soluble acid distribution in poly(lactide-co-glycolide).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Chemical stability of peptides in polymers. 2. Discriminating between solvent and plasticizing effects of water on peptide deamidation in poly(vinylpyrrolidone).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Studies on the mechanism of aspartic acid cleavage and glutamine deamidation in the acidic degradation of glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Stability of insulin during the erosion of poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Endogenous DNA damage in humans: a review of quantitative data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Protein instability in poly(lactic-co-glycolic acid) microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Peptide acylation by poly(alpha-hydroxy esters).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Development of pegylated interferons for the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Effects of PEG conjugation on insulin properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Chemistry for peptide and protein PEGylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Effective drug delivery by PEGylated drug conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Pegylation enhances protein stability during encapsulation in PLGA microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Stabilization of recombinant interferon-alpha by pegylation for encapsulation in PLGA microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Pegylated recombinant human epidermal growth factor (rhEGF) for sustained release from biodegradable PLGA microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Effect of the covalent modification of horseradish peroxidase with poly(ethylene glycol) on the activity and stability upon encapsulation in polyester microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Effect of the covalent modification with poly(ethylene glycol) on alpha-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic) microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

PEGylated insulin in PLGA microparticles. In vivo and in vitro analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

PEGylation does not impair insulin efficacy in three-dimensional cartilage culture: an investigation toward biomimetic polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Site-specific attachment of polyethylene glycol-like oligomers to proteins and peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Impurity formation studies with peptide-loaded polymeric microspheres Part II. In vitro evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Impurity formation studies with peptide-loaded polymeric microspheres Part I. In vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly(D,L-lactide-co-glycolide).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

PEGylation of octreotide: II. Effect of N-terminal mono-PEGylation on biological activity and pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Preparation and stability of poly(ethylene glycol) (PEG)ylated octreotide for application to microsphere delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Control of encapsulation efficiency and initial burst in polymeric microparticle systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

A potential approach for decreasing the burst effect of protein from PLGA microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Bioconjugation in pharmaceutical chemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Prolonging the action of protein and peptide drugs by a novel approach of reversible polyethylene glycol modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

High-yield production of biologically active mono-PEGylated salmon calcitonin by site-specific PEGylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Synthesis and characterization of poly(ethylene glycol)-insulin conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Oligo oligarchy-the surprisingly small world of aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

Pegaptanib for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1427

10.1517/14712598.7.9.1427

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference